Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22136324 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Humalog;   Drug: Humulin-R;   Drug: Recombinant human hyaluronidase PH20 (rHuPH20)

Indicates status has not been verified in more than two years